Pfizer beats profit forecast, helped by cost cuts
REUTERS - Pfizer Inc (PFE.N) reported better-than-expected quarterly earnings as cost controls partly offset plunging sales of its Lipitor cholesterol fighter, now facing competition from cheaper generics.
The largest U.S. drugmaker said on Tuesday that it earned $1.79 billion, or 24 cents per share, in the first quarter. That compared with $2.2 billion, or 28 cents per share, in the year-earlier period when results were hurt by a litigation charge and costs of revamping research operations.
Excluding special items, Pfizer earned 58 cents per share. Analysts, on average, had expected 56 cents per share.
The company's revenue fell 7 percent to $15.41 billion, a bit below Wall Street expectations of $15.47 billion.
(Reporting By Ransdell Pierson)
- Tweet this
- Share this
- Digg this
- REFILE-British Muslims urge cooperation in Foley murder hunt
- UPDATE 5-U.S. aid workers who survived Ebola leave Atlanta hospital
- Ukraine's Poroshenko talks tough ahead of meetings with Merkel, Putin
- U.S. strikes have slowed Iraq militants but not weakened them - Pentagon
- UPDATE 4-Family Dollar spurns Dollar General bid on antitrust concerns
Government officials painted an upbeat picture for the economy on Thursday as it struggles to emerge from the longest spell of sub-par growth in decades and promised to tighten up risk management at the country's dominant state banks. Full Article